Wolverine Trading, LLC Genprex, Inc. Put Options Transaction History

Wolverine Trading, LLC

6 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2022 Aug 15, 2022	SELL	$1.28 - $2.31 $12,800 - $23,100	-10,000 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$1.82 - $3.5 $30,758 - $59,150	-16,900 Reduced 62.83%	10,000 $23,000
Q3 2021 Nov 12, 2021	BUY	$2.59 - $3.36 $6,993 - $9,072	2,700 Added 11.16%	26,900 $71,000
Q2 2021 Aug 06, 2021	BUY	$3.11 - $4.87 $3,110 - $4,870	1,000 Added 4.31%	24,200 $83,000
Q1 2021 May 14, 2021	BUY	$3.66 - $7.67 $14,274 - $29,913	3,900 Added 20.21%	23,200 $94,000
Q4 2020 Feb 12, 2021	BUY	$3.03 - $5.51 $58,478 - $106,343	19,300 New	19,300 $85,000

600

Ticker GNPX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,020,300
Market Cap $76.8M
Description
Genprex, Inc., a clinical-stage gene therapy company, focuses on developing therapies for patients with cancer and diabetes. Its lead product candidate is REQORSA (GPX-001) to treat non-small cell lung cancer and small cell lung cancer. The company is also developing GPX-002, a preclinical stage gene therapy for diabetes. Genprex, Inc. was incor...

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Trading, LLC with notifications on news.